Clifford Goodman, PhD of Lewin Group gives an overview of the types of evidence that the National Comprehensive Cancer Network (NCCN) look for when it comes to their guidelines. He states that the NCCN panel is looking for data from not only clinical trials, but other complementary sources of data. This was recorded at the 2017 National Comprehensive Cancer Network (NCCN) Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care in Orlando, Florida.
Where is the Threshold Set for Evidence That NCCN Guidelines Seek
